374 reports of this reaction
1.4% of all DOCOSANOL reports
#14 most reported adverse reaction
PRODUCT COMPLAINT is the #14 most commonly reported adverse reaction for DOCOSANOL, manufactured by Haleon US Holdings LLC. There are 374 FDA adverse event reports linking DOCOSANOL to PRODUCT COMPLAINT. This represents approximately 1.4% of all 26,055 adverse event reports for this drug.
Patients taking DOCOSANOL who experience product complaint should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT COMPLAINT is a less commonly reported adverse event for DOCOSANOL, but still significant enough to appear in the safety profile.
In addition to product complaint, the following adverse reactions have been reported for DOCOSANOL:
The following drugs have also been linked to product complaint in FDA adverse event reports:
PRODUCT COMPLAINT has been reported as an adverse event in 374 FDA reports for DOCOSANOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT COMPLAINT accounts for approximately 1.4% of all adverse event reports for DOCOSANOL, making it a notable side effect.
If you experience product complaint while taking DOCOSANOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.